Last checked at 6 Jan 2015 14:50
Epistem Holdings Plc ("Epistem" or the "Company")
Directors' Shareholdings
Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.
As a result of the subscription for Partnership Shares and the award of Matching Shares, executive Directors, Matthew Walls, Dr Catherine Booth, John Rylands and Dr Allan Brown each increased their beneficial interests in the Company by 1,083 ordinary shares of 1.5p each. These shares were acquired on 28 April 2014, 28 May 2014, 27 June 2014, 28 July 2014, 28 August 2014, 29 September 2014, 28 October 2014, 28 November 2014 and 30 December 2014 at prices of 328p, 338p, 338p, 330p, 320p, 303p, 288p, 278p and 278p respectively.
Following these transactions, the current beneficial interests of the executive Directors are set out below:
Ordinary Shares %
Matthew Walls 12,370 0.12%
Dr Catherine Booth 986,725 9.86%
John Rylands 196,623 1.96%
Dr Allan Brown 1,311 0.01%
For further details please contact:
Epistem Holdings Plc
Matthew Walls: Chief Executive Officer ++44 (0)161 606 7258
John Rylands: Finance Director
Peel Hunt LLP
James Steel ++44 (0)207 418 8900
Clare Terlouw
Walbrook PR
Mike Wort ++44 (0)207 933 8780
Anna Dunphy
Please see http://www.epistem.co.ukfor additional information.